Video Experimental Relacionado
Updated: Jul 9, 2026
12:58
A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment
Published on: May 25, 2017
Resistencia de Plasmodium a la cloroquina y la búsqueda de un sustituto del fármaco antipalúdico
1Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, Bethesda, MD 20892, USA. tew@helix.nih.gov
Science (New York, N.Y.)
|October 5, 2002
Resumen
Una nueva investigación revela conocimientos sobre los mecanismos de resistencia a la cloroquina en la malaria. Los esfuerzos de descubrimiento de fármacos están identificando nuevos compuestos prometedores eficaces contra las cepas resistentes.
Área de la Ciencia:
- Malariología Malariología.
- Farmacología Farmacología.
- Genética La genética.
Sus antecedentes:
- La cloroquina ha sido una piedra angular del tratamiento de la malaria.
- La aparición de resistencia a la cloroquina ha limitado su efectividad.
- Comprender los mecanismos de resistencia es crucial para el desarrollo de nuevas terapias.
Objetivo del estudio:
- Para aclarar los fundamentos genéticos y bioquímicos de la resistencia a la cloroquina.
- Para identificar nuevos fármacos candidatos con actividad contra la malaria resistente a la cloroquina.
Principales métodos:
- Análisis genético para identificar marcadores de resistencia.
- Ensayos bioquímicos para estudiar las interacciones entre fármacos y objetivos.
- Cribado de descubrimiento de fármacos para nuevas pistas de antipalúdicos.
Principales resultados:
- Nueva información genética y bioquímica sobre los mecanismos de resistencia a la cloroquina.
- La identificación del descubrimiento de fármacos conduce a propiedades farmacéuticas favorables.
- Eficacia demostrada de nuevas pistas contra los parásitos de la malaria resistentes a la cloroquina.
Conclusiones:
- Los avances en la investigación genética y bioquímica están mejorando nuestra comprensión de la resistencia a la cloroquina.
- El descubrimiento de fármacos está produciendo nuevos tratamientos prometedores para la malaria, particularmente para las formas resistentes.
Videos de Conceptos Relacionados
01:29Drugs for Treatment of Ulcerative Colitis in IBD
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide generation.
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...
01:29Inflammatory Bowel Disease IV: Pharmacological Management
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
01:29Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
01:25Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...